Posts tagged with the keyword: ‘Industries’

This $20 Billion Hedge Fund Is Gobbling Up Teva Pharmaceutical Industries Limited – Motley Fool

This $20 Billion Hedge Fund Is Gobbling Up Teva Pharmaceutical Industries Limited - Motley Fool

This Billion Hedge Fund Is Gobbling Up Teva Pharmaceutical Industries Limited – Motley Fool Source: Flickr via user Lendingmemo. According to the third-quarter 13F filings with the SEC, Paulson & Co., a $ 20 billion hedge fund headed by noted investor John Paulson, raised its stake in generic-drug maker Teva Pharmaceutical Industries (NYSE:TEVA) by an […]

Teva Pharmaceutical Industries Ltd. Sees Stronger 2015 After Q3 Results – Motley Fool

Teva Pharmaceutical Industries Ltd. Sees Stronger 2015 After Q3 Results - Motley Fool

Teva Pharmaceutical Industries Ltd. Sees Stronger 2015 After Q3 Results – Motley Fool Image Source: Wikimedia Commons. Change is certainly in the air in the generic pharmaceuticals industry, with a wave of mergers and acquisitions over the last year. Israel-based Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is no stranger to this change, with the company involved in […]

Rival Industries Sweet-Talk the Public – New York Times

Rival Industries Sweet-Talk the Public - New York Times

Rival Industries Sweet-Talk the Public – New York Times HTTP/1.1 302 Found Date: Wed, 12 Feb 2014 03:03:29 GMT Server: Apache Set-Cookie: NYT-S=0MXD0Qb0kai3/DXrmvxADeHyXsYiMUyqhEdeFz9JchiAIUFL2BEX5FWcV.Ynx4rkFI; expires=Fri, 14-Mar-2014 03:03:29 GMT; path=/; domain=.nytimes.com Location: http://www.nytimes.com/2014/02/12/business/rival-industries-sweet-talk-the-public.html?_r=0 Content-Length: 0 Cneonction: close Content-Type: text/html; charset=UTF-8 HTTP/1.1 200 OK Server: Apache Cache-Control: no-cache Content-Type: text/html; charset=utf-8 Content-Length: 37434 Accept-Ranges: bytes Date: Wed, 12 […]

Big Changes and Small Moves for Teva Pharmaceutical Industries Ltd. – Motley Fool

Big Changes and Small Moves for Teva Pharmaceutical Industries Ltd. - Motley Fool

Big Changes and Small Moves for Teva Pharmaceutical Industries Ltd. – Motley Fool By David Williamson | More ArticlesJanuary 12, 2014 | Teva Pharmaceuticals (NYSE: TEVA  ) has been engulfed with turmoil. Its blockbuster MS franchise is facing a new competitive thereat, and the company is staring down the barrel of its patent expiration. Then in […]

    Copyright 2011-2013, www.EHealthJournal.net, Web Site Development & SEO by SecondEffort, Inc.